Resono Ophthalmic Srl

📍 SANDRIGO, Italy👥 5 employees💰 Last funded Sep 2014
Medical Equipment Manufacturing
LinkedIn
Resono Ophthalmic is an innovative Italian company created in 2014 to develop and commercialize cutting-edge therapeutic devices for ophthalmology. The key feature of these devices is the Quantum Molecular Resonance treatment. QMR® is a patented technology which stimulates the natural regeneration of cells and tissue via low-power and high-frequency electric fields. Resono first applied this technique to treat Dry Eye Disease (DED) with Rexon-Eye®, a patented CE-marked medical device. So far, clinical trials in Italy and abroad have proved with evidence that Rexon-Eye® is a safe, effective, and long-term treatment option for all types of DED. The benefits of QMR in stimulating cell and tissue regeneration are currently understudying for the application in other eye diseases. For more information and technical details, visit our website. *QMR® is a registered trademark by Telea Electronic Engineering.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Resono Ophthalmic Srl?
Resono Ophthalmic Srl has 1 investors on record on gritt.io.
When did Resono Ophthalmic Srl last raise funding?
The most recent investment in Resono Ophthalmic Srl recorded on gritt.io was in September 2014.
What industry is Resono Ophthalmic Srl in?
Resono Ophthalmic Srl operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Resono Ophthalmic Srl based?
Resono Ophthalmic Srl is headquartered in SANDRIGO, Italy.